Location: Boston, MA
CIK: 0001703031 · Show all filings
Period: Q4 2023 (← Previous) (Next →)
Filing Date: Feb 13, 2024
Total Value: $1.043B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NUVL | NUVALENT INC | 3,577,267 | $263M | 25.2% | $28.96 | +113.6% | COM | 670703107 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 10,473,913 | $117M | 11.2% | $10.64 | -13.9% | ORDINARY SHARES | N62509109 |
| PHVS | PHARVARIS N V | 3,904,319 | $110M | 10.5% | $23.89 | -15.3% | COM | N69605108 |
| IRON | DISC MEDICINE INC | 1,332,545 | $76.97M | 7.4% | $22.28 | +129.8% | COM | 254604101 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 324,619 | $75.11M | 7.2% | $174.99 | 0.0% | COM | 558868105 |
| SVRA | SAVARA INC | 14,232,751 | $66.89M | 6.4% | $1.87 | +105.2% | COM | 805111101 |
| CABA | CABALETTA BIO INC | 2,000,000 | $45.4M | 4.4% | $10.85 | +54.9% | COM | 12674W109 |
| ANNX | ANNEXON INC | 8,061,719 | $36.6M | 3.5% | $11.72 | -78.9% | COM | 03589W102 |
| RVMD | REVOLUTION MEDICINES INC | 1,112,396 | $31.9M | 3.1% | $24.03 | 0.0% | COM | 76155X100 |
| TNGX | TANGO THERAPEUTICS INC | 2,892,663 | $28.64M | 2.7% | $10.01 | -13.3% | COM | 87583X109 |
| NTRA | NATERA INC | 400,197 | $25.07M | 2.4% | $41.20 | +21.3% | COM | 632307104 |
| SYRS | SYROS PHARMACEUTICALS INC | 2,749,808 | $21.42M | 2.1% | $5.62 | -39.1% | COM NEW | 87184Q206 |
| — | MERSANA THERAPEUTICS INC | 8,663,673 | $20.1M | 1.9% | $12.65 | — | COM | 59045L106 |
| SLDB | SOLID BIOSCIENCES INC | 3,130,422 | $19.22M | 1.8% | $6.55 | -51.2% | COM NEW | 83422E204 |
| NRIX | NURIX THERAPEUTICS INC | 1,822,883 | $18.81M | 1.8% | $21.10 | -67.5% | COM | 67080M103 |
| — | MARINUS PHARMACEUTICALS INC | 1,431,058 | $15.56M | 1.5% | $15.48 | — | COM NEW | 56854Q200 |
| — | X4 PHARMACEUTICALS INC | 16,915,784 | $14.18M | 1.4% | $2.56 | — | COM | 98420X103 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 3,000,000 | $9.69M | 0.9% | $26.87 | -89.9% | COM | 03969K108 |
| CCCC | C4 THERAPEUTICS INC | 1,642,210 | $9.278M | 0.9% | $29.00 | -92.1% | COM STK | 12529R107 |
| IVVD | INVIVYD INC | 1,937,207 | $7.633M | 0.7% | $37.11 | -94.9% | COM | 00534A102 |
| AVIR | ATEA PHARMACEUTICALS INC | 2,485,638 | $7.581M | 0.7% | $32.23 | -90.6% | COM | 04683R106 |
| RPID | RAPID MICRO BIOSYSTEMS INC | 8,434,560 | $6.242M | 0.6% | $20.66 | -95.0% | CLASS A COM | 75340L104 |
| NAUT | NAUTILUS BIOTECHNOLOGY INC | 2,000,000 | $5.98M | 0.6% | $10.83 | -73.6% | COM | 63909J108 |
| — | 2SEVENTY BIO INC | 1,331,801 | $5.687M | 0.5% | $18.15 | — | COMMON STOCK | 901384107 |
| ACRS | ACLARIS THERAPEUTICS INC | 3,500,000 | $3.675M | 0.4% | $12.42 | -75.4% | COM | 00461U105 |
| XLO | XILIO THERAPEUTICS INC | 2,805,413 | $1.543M | 0.1% | $17.03 | -91.7% | COM | 98422T100 |
| NAMSW | NEWAMSTERDAM PHARMA COMPANY | 100,000 | $313K | 0.0% | $0.86 | — | *W EXP 11/22/202 | N62509117 |